Business
IceCure Reports First Quarter 2026 Financial Results: ProSense® Sales Increase Substantially in the U.S. and North America
IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical tumor removal, today reported financial results as of and for the three months ended March 31, 2026 as well as recent commercial and clinical updates. Revenues, gross profits and gross margins all increased during the first quarter of 2026 compared to the first quarter of 2025 including:
About this update from Icecure Medical Ltd.
[{"type":"text","content":"Pent-up demand immediately following FDA clearance generates 46% increase in active customer accounts using ProSense® as of the end of the first quarter 2026, compared with prior to FDA clearance","length":195,"tagName":"p","attribs":{}},{"type":"text","content":"Accelerating adoption of ProSense® driven by several growth catalysts, including FDA clearance, expanding reimbursement framework, media coverage, growing body of clinical data and recommendation of cryoablation for breast cancer in leading clinical guidelines","length":260,"tagName":"p","attribs":{}},{"type":"text","content":"Conference call to be held today at 11:00 am Eastern Time","length":57,"tagName":"p","attribs":{}},{"type":"text","content":"CAESAREA, Israel, May 12, 2026 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical tumor removal, today reported financial results as of and for the three months ended March 31, 2026 as well as recent commercial and clinical updates. Revenues, gross profits and gross margins all increased during the first quarter of 2026 compared to the first quarter of 2025 including:","length":564,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Global revenue rose 26%","length":23,"tagName":"p"}]},{"val":[{"type":"text","content":"Sales in North America increased 84%","length":36,"tagName":"p"}]},{"val":[{"type":"text","content":"Sales in the U.S. grew 31%","length":26,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":85,"olType":false},{"type":"image","alt":"IceCure Medical Logo","displaySize":"","headline":null,"caption":"IceCure Medical Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":200,"url":"https://media.zenfs.com/en/prnewswire.com/b733b9648e0c5c7b36e9d5bf48d042cc"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/0v6Nk71FF.FRuk4jS6_9xA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTM1Mw--/https://media.zenfs.com/en/prnewswire.com/b733b9648e0c5c7b36e9d5bf48d042cc","width":400,"height":200},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/MIBMDMvlhp9BQMBJkZWWIQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTMyMA--/https://media.zenfs.com/en/prnewswire.com/b733b9648e0c5c7b36e9d5bf4...